Citations

Citations to this article as recorded by  

• Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies
  Xiaojie Zhang, Min An, Juntao Zhang, Yumeng Zhao, Yanhua Liu
  Journal of Drug Targeting.2024; 32(3): 241.     CrossRef
• Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
  Hamed M. El-Shora, Nessma A. El-Zawawy, Mohamed A. Abd El-Rheem, Metwally A. Metwally
  BMC Microbiology.2024;[Epub]     CrossRef
• Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
  Yue Yin, Weibo Feng, Jie Chen, Xilang Chen, Guodong Wang, Shuai Wang, Xiao Xu, Yongzhan Nie, Daiming Fan, Kaichun Wu, Limin Xia
  Experimental Hematology & Oncology.2024;[Epub]     CrossRef
• Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment
  Jing Wang, Yuanli He, Feiming Hu, Chenchen Hu, Yuanjie Sun, Kun Yang, Shuya Yang
  International Journal of Molecular Sciences.2024; 25(22): 12223.     CrossRef
• L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction
  Amany A. Hassabo, Mohamed Abdelraof, Rasha M. Allam
  International Journal of Biological Macromolecules.2023; 224: 634.     CrossRef
• Arginine transportation mechanism through cationic amino acid transporter 1: insights from molecular dynamics studies
  Maral Afshinpour, Hamid Mahdiuni
  Journal of Biomolecular Structure and Dynamics.2023; 41(23): 13580.     CrossRef
• Autophagy and autophagy-related pathways in cancer
  Jayanta Debnath, Noor Gammoh, Kevin M. Ryan
  Nature Reviews Molecular Cell Biology.2023; 24(8): 560.     CrossRef
• Amino acids in hematologic malignancies: Current status and future perspective
  Mengyao Wang, Ailin Zhao, Meng Li, Ting Niu
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
  Melissa M. Phillips, Iuliia Pavlyk, Michael Allen, Essam Ghazaly, Rosalind Cutts, Josephine Carpentier, Joe Scott Berry, Callum Nattress, Shenghui Feng, Gunnel Hallden, Claude Chelala, John Bomalaski, Jeremy Steele, Michael Sheaff, Frances Balkwill, Peter
  Pharmacological Reports.2023; 75(3): 570.     CrossRef
• Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
  Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Octavian Sabin Tataru, Riccardo Autorino, Michele Battaglia, Pasquale Ditonno, Giuseppe Lucarelli
  Biomedicines.2023; 11(4): 1071.     CrossRef
• Enzyme Cascade with Horseradish Peroxidase Readout for High-Throughput Screening and Engineering of Human Arginase-1
  Jaime Fernández De Santaella, Jin Ren, Rosario Vanella, Michael A. Nash
  Analytical Chemistry.2023; 95(18): 7150.     CrossRef
• Human arginase I: a potential broad-spectrum anti-cancer agent
  J. Anakha, Yenisetti Rajendra Prasad, Nisha Sharma, Abhay H. Pande
  3 Biotech.2023;[Epub]     CrossRef
• Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
  Federica Borea, Marika A. Franczak, Maria Garcia, Matteo Perrino, Nadia Cordua, Ryszard T. Smolenski, Godefridus J. Peters, Rafal Dziadziuszko, Armando Santoro, Paolo A. Zucali, Elisa Giovannetti
  International Journal of Molecular Sciences.2023; 24(11): 9165.     CrossRef
• Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy
  Ángela Marrugal, Irene Ferrer, Álvaro Quintanal-Villalonga, Laura Ojeda, María Dolores Pastor, Ricardo García-Luján, Amancio Carnero, Luis Paz-Ares, Sonia Molina-Pinelo
  International Journal of Molecular Sciences.2023; 24(18): 13830.     CrossRef
• Chronic Stress Blocks the Endometriosis Immune Response by Metabolic Reprogramming
  Chong Lu, Jing Xu, Ke Li, Jing Wang, Yilin Dai, Yiqing Chen, Ranran Chai, Congjian Xu, Yu Kang
  International Journal of Molecular Sciences.2023; 25(1): 29.     CrossRef
• Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
  Danyu Du, Chan Liu, Mengyao Qin, Xiao Zhang, Tao Xi, Shengtao Yuan, Haiping Hao, Jing Xiong
  Acta Pharmaceutica Sinica B.2022; 12(2): 558.     CrossRef
• The effect of l-arginine supplementation and surgical trauma on the frequency of myeloid-derived suppressor cells and T lymphocytes in tumour and blood of colorectal cancer patients
  Jarosław Szefel, Tomasz Ślebioda, Jakub Walczak, Wiesław Janusz Kruszewski, Mariusz Szajewski, Maciej Ciesielski, Marcin Stanisławowski, Tomasz Buczek, Sylwia Małgorzewicz, Anna Owczarzak, Ewa Aleksandrowicz-Wrona, Grzegorz Krzykowski
  Advances in Medical Sciences.2022; 67(1): 66.     CrossRef
• Dysbiosis of skin microbiome and gut microbiome in melanoma progression
  Chahrazed Mekadim, Helena Kupcova Skalnikova, Jana Cizkova, Veronika Cizkova, Anna Palanova, Vratislav Horak, Jakub Mrazek
  BMC Microbiology.2022;[Epub]     CrossRef
• Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming
  Muhua Chen, Chunfeng Zhang, Wei Liu, Xiaojuan Du, Xiaofeng Liu, Baocai Xing
  Molecular Therapy.2022; 30(6): 2354.     CrossRef
• Liver-resident memory T cells: life in lockdown
  Laura J. Pallett, Mala K. Maini
  Seminars in Immunopathology.2022; 44(6): 813.     CrossRef
• Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
  Xiaoshuang Hou, Sui Chen, Po Zhang, Dongsheng Guo, Baofeng Wang
  Frontiers in Oncology.2022;[Epub]     CrossRef
• A virulence factor as a therapeutic: the probiotic Enterococcus faecium SF68 arginine deiminase inhibits innate immune signaling pathways
  Fereshteh Ghazisaeedi, Jochen Meens, Bianca Hansche, Sven Maurischat, Peter Schwerk, Ralph Goethe, Lothar H. Wieler, Marcus Fulde, Karsten Tedin
  Gut Microbes.2022;[Epub]     CrossRef
• Cell metabolomics study on synergistic anti‐hepatocellular carcinoma effect of Aidi injection combined with doxorubicin
  Yanli Wang, Xiaoqing Zhu, Kailiang Wang, Ying Cai, Chunhua Liu, Jie Pan, Jia Sun, Ting Liu, Yong Huang, Yongjun Li, Yuan Lu
  Biomedical Chromatography.2022;[Epub]     CrossRef
• Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts
  Dong Hang, Xiaolin Yang, JiaYi Lu, Chong Shen, Juncheng Dai, Xiangfeng Lu, Guangfu Jin, Zhibin Hu, Dongfeng Gu, Hongxia Ma, Hongbing Shen
  International Journal of Cancer.2022; 151(12): 2144.     CrossRef
• Role of 3'-Deoxy-3'-[18F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase
  Teresa A. Szyszko, Joel T. Dunn, Melissa M. Phillips, John Bomalaski, Michael T. Sheaff, Steve Ellis, Lucy Pike, Vicky Goh, Gary J.R. Cook, Peter W. Szlosarek
  JTO Clinical and Research Reports.2022; 3(9): 100382.     CrossRef
• Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
  Joséphine Carpentier, Iuliia Pavlyk, Uma Mukherjee, Peter E Hall, Peter W Szlosarek
  Lung Cancer: Targets and Therapy.2022; Volume 13: 53.     CrossRef
• Human arginase 1, a Jack of all trades?
  J. Anakha, Priyanka S. Kawathe, Sayantap Datta, Snehal Sainath Jawalekar, Uttam Chand Banerjee, Abhay H. Pande
  3 Biotech.2022;[Epub]     CrossRef
• Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy
  Remya Nair, Pulkit Gupta, Mala Shanmugam
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein
  Haein Lee, Geunhwa Park, Seulha Kim, Boram Son, Jinmyoung Joo, Hee Ho Park, Tai Hyun Park
  Applied Microbiology and Biotechnology.2022; 106(22): 7531.     CrossRef
• Cationic amino acid transporter-1 (CAT-1) promotes fibroblast-like synoviocyte proliferation and cytokine secretion by taking up L-arginine in rheumatoid arthritis
  Ying Lu, Chongbo Hao, Shanshan Yu, Zuan Ma, Xuelian Fu, Mingqing Qin, Menglei Ding, Zengguang Xu, Lieying Fan
  Arthritis Research & Therapy.2022;[Epub]     CrossRef
• Research progress in inducing immunogenic cell death of tumor cells
  Deqian Xie, Qifei Wang, Guangzhen Wu
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Unbalanced Glutamine Partitioning between CD8T Cells and Cancer Cells Accompanied by Immune Cell Dysfunction in Hepatocellular Carcinoma
  Jianfei Chen, Rui Wang, Zhongliang Liu, Jun Fan, Shenglu Liu, Shunde Tan, Xinkai Li, Bo Li, Xiaoli Yang
  Cells.2022; 11(23): 3924.     CrossRef
• Plasma amino acids indicate glioblastoma with ATRX loss
  Ernest Jan Bobeff, Dorota Szczesna, Michał Bieńkowski, Karolina Janczar, Malgorzata Chmielewska-Kassassir, Karol Wiśniewski, Wielisław Papierz, Lucyna Alicja Wozniak, Dariusz Jan Jaskólski
  Amino Acids.2021; 53(1): 119.     CrossRef
• Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment
  Kuo-Ming Yu, Tammy Pui-shi Pang, Murray Cutler, Min Tian, Lynn Huang, Johnson Yiu-Nam Lau, Sai-Fung Chung, Thomas Wai-hung Lo, Thomas Yun-chung Leung
  Life Sciences.2021; 264: 118674.     CrossRef
• Dietary intervention as a therapeutic for cancer
  Mami Morita, Kei Kudo, Hiroshi Shima, Nobuhiro Tanuma
  Cancer Science.2021; 112(2): 498.     CrossRef
• Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers
  Gaurav Pathria, Ze’ev A. Ronai
  Cell Metabolism.2021; 33(1): 9.     CrossRef
• Pegylated arginine deiminase depletes plasma arginine but maintains tissue arginine availability in young pigs
  Mahmoud A. Mohammad, Inka C. Didelija, Barbara Stoll, Trung C. Nguyen, Juan C. Marini
  American Journal of Physiology-Endocrinology and Metabolism.2021; 320(3): E641.     CrossRef
• Targeting the Proline–Glutamine–Asparagine–Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy
  Macus Kuo, Helen Chen, Lynn Feun, Niramol Savaraj
  Pharmaceuticals.2021; 14(1): 72.     CrossRef
• Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy
  Mylène Tajan, Marc Hennequart, Eric C. Cheung, Fabio Zani, Andreas K. Hock, Nathalie Legrave, Oliver D. K. Maddocks, Rachel A. Ridgway, Dimitris Athineos, Alejandro Suárez-Bonnet, Robert L. Ludwig, Laura Novellasdemunt, Nikolaos Angelis, Vivian S. W. Li,
  Nature Communications.2021;[Epub]     CrossRef
• Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro
  Zhiying Huang, Haifeng Hu
  Molecules.2021; 26(2): 511.     CrossRef
• The cancer metabolic reprogramming and immune response
  Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Yaqian Han, Nayiyuan Wu, Pin Yi, Lu Tang, Qing Pan, Shan Rao, Jiaxin Liang, Yanyan Tang, Min Su, Xia Luo, Yiqing Yang, Yingrui Shi, Hui Wang, Yujuan Zhou, Qianjin Liao
  Molecular Cancer.2021;[Epub]     CrossRef
• Metabolomic characterisation of progression and spontaneous regression of melanoma in the melanoma-bearing Libechov minipig model
  Martin Kertys, Marian Grendar, Vratislav Horak, Nela Zidekova, Helena Kupcova Skalnikova, Juraj Mokry, Erika Halasova, Jan Strnadel
  Melanoma Research.2021; 31(2): 140.     CrossRef
• Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia
  Hui‐Jen Tsai, Hui‐Hua Hsiao, Ya‐Ting Hsu, Yi‐Chang Liu, Hsiao‐Wen Kao, Ta‐Chih Liu, Shih‐Feng Cho, Xiaoxing Feng, Amanda Johnston, John S. Bomalaski, Ming‐Chung Kuo, Tsai‐Yun Chen
  Cancer Medicine.2021; 10(9): 2946.     CrossRef
• Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
  Mark D. Badeaux, Annah S. Rolig, Giulia Agnello, Danlee Enzler, Melissa J. Kasiewicz, Leslie Priddy, Jason F. Wiggins, Alexander Muir, Mark R. Sullivan, Jessica Van Cleef, Christopher Daige, Matthew G. Vander Heiden, Venkatesh Rajamanickam, James E. Woold
  Cancer Immunology Research.2021; 9(4): 415.     CrossRef
• Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor
  Zizheng Zou, Xiyuan Hu, Tiao Luo, Zhengnan Ming, Xiaodan Chen, Li Xia, Wensong Luo, Jijia Li, Na Xu, Ling Chen, Dongsheng Cao, Min Wen, Fanrong Kong, Kunjian Peng, Yuanzhu Xie, Xuan Li, Dayou Ma, Chuanyu Yang, Ceshi Chen, Wenjun Yi, Ousheng Liu, Suyou Liu
  Nature Communications.2021;[Epub]     CrossRef
• Arginine Metabolism and Its Potential in Treatment of Colorectal Cancer
  Tao Du, Junyi Han
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• Targeting Immunometabolism in Glioblastoma
  Aditya A. Mohan, William H. Tomaszewski, Aden P. Haskell-Mendoza, Kelly M. Hotchkiss, Kirit Singh, Jessica L. Reedy, Peter E. Fecci, John H. Sampson, Mustafa Khasraw
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level
  Serena Pillozzi, Andrea Bernini, Ilaria Palchetti, Olivia Crociani, Lorenzo Antonuzzo, Domenico Campanacci, Guido Scoccianti
  Cancers.2021; 13(12): 3044.     CrossRef
• Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment
  Neha Kumari, Saurabh Bansal
  Cancer Chemotherapy and Pharmacology.2021; 88(4): 565.     CrossRef
• Metabolic Alterations in Preneoplastic Development Revealed by Untargeted Metabolomic Analysis
  Henna Myllymäki, Jeanette Astorga Johansson, Estefania Grados Porro, Abigail Elliot, Tessa Moses, Yi Feng
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• Dysregulated Alanine as a Potential Predictive Marker of Glioma—An Insight from Untargeted HRMAS-NMR and Machine Learning Data
  Safia Firdous, Rizwan Abid, Zubair Nawaz, Faisal Bukhari, Ammar Anwer, Leo L. Cheng, Saima Sadaf
  Metabolites.2021; 11(8): 507.     CrossRef
• Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer
  Peter W. Szlosarek, Akhila G. Wimalasingham, Melissa M. Phillips, Peter E. Hall, Pui Ying Chan, John Conibear, Louise Lim, Sukaina Rashid, Jeremy Steele, Paula Wells, Chiung‐Fang Shiu, Chih‐Ling Kuo, Xiaoxing Feng, Amanda Johnston, John Bomalaski, Stephen
  Cancer Medicine.2021; 10(19): 6642.     CrossRef
• Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
  Yaolin Xu, Lijie He, Qiang Fu, Junzhe Hu
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Fueling T-cell Antitumor Immunity: Amino Acid Metabolism Revisited
  Chenfeng Han, Minmin Ge, Ping-Chih Ho, Lianjun Zhang
  Cancer Immunology Research.2021; 9(12): 1373.     CrossRef
• Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
  Andreia Matos, Marcos Carvalho, Manuel Bicho, Ricardo Ribeiro
  Nutrients.2021; 13(12): 4503.     CrossRef
• GC/MS-based differential metabolic profiling of human peptic ulcer disease to study Helicobacter pylori-induced metabolic perturbations
  GAGANJOT GUPTA, DEEPAK BANSAL, ANSHULA SHARMA, TAWSEEF AHMAD, ATUL SACHDEV, AJAZ AHMAD, HAMED A. EL-SEREHY, BALJINDER KAUR
  BIOCELL.2021; 45(5): 1299.     CrossRef
• New aspects of amino acid metabolism in cancer
  Lisa Vettore, Rebecca L. Westbrook, Daniel A. Tennant
  British Journal of Cancer.2020; 122(2): 150.     CrossRef
• Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1
  Giulia Agnello, Susan E. Alters, Scott W. Rowlinson
  Translational Research.2020; 217: 11.     CrossRef
• Tumour metabolism and its unique properties in prostate adenocarcinoma
  David A. Bader, Sean E. McGuire
  Nature Reviews Urology.2020; 17(4): 214.     CrossRef
• Dietary Approaches to Cancer Therapy
  Mylène Tajan, Karen H. Vousden
  Cancer Cell.2020; 37(6): 767.     CrossRef
• Myeloid Cell-Derived Arginase in Cancer Immune Response
  Tomasz M. Grzywa, Anna Sosnowska, Paweł Matryba, Zuzanna Rydzynska, Marcin Jasinski, Dominika Nowis, Jakub Golab
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer
  Peter E. Hall, Neal Ready, Amanda Johnston, John S. Bomalaski, Ralph R. Venhaus, Michael Sheaff, Lee Krug, Peter W. Szlosarek
  Clinical Lung Cancer.2020; 21(6): 527.     CrossRef
• Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
  Caitlyn B. Brashears, Meltem Barlin, William R. Ehrhardt, Richa Rathore, Matthew Schultze, Shin-Chen Tzeng, Brian A. Van Tine, Jason M. Held
  Cell Death & Disease.2020;[Epub]     CrossRef
• The free amino acid profiles and metabolic biomarkers of predicting the chemotherapeutic response in advanced sarcoma patients
  B. Jia, W. Wang, S. Lin, L. Shi, Y. Li, Y. Gu, F. Gao, Y. Qin
  Clinical and Translational Oncology.2020; 22(12): 2213.     CrossRef
• Exercise May Affect Metabolism in Cancer-Related Cognitive Impairment
  Muhammad Shahid, Jayoung Kim
  Metabolites.2020; 10(9): 377.     CrossRef
• Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors
  Seema Gupta, Bilikere S. Dwarakanath
  Current Medicinal Chemistry.2020; 27(24): 4002.     CrossRef
• Combinatory Treatment of Canavanine and Arginine Deprivation Efficiently Targets Human Glioblastoma Cells via Pleiotropic Mechanisms
  Olena Karatsai, Pavel Shliaha, Ole N. Jensen, Oleh Stasyk, Maria Jolanta Rędowicz
  Cells.2020; 9(10): 2217.     CrossRef
• The Janus-like role of proline metabolism in cancer
  Lynsey Burke, Inna Guterman, Raquel Palacios Gallego, Robert G. Britton, Daniel Burschowsky, Cristina Tufarelli, Alessandro Rufini
  Cell Death Discovery.2020;[Epub]     CrossRef
• Development of cancer prognostic signature based on pan-cancer proteomics
  Weiguo Huang, Jianhui Chen, Wanqing Weng, Yukai Xiang, Hongqi Shi, Yunfeng Shan
  Bioengineered.2020; 11(1): 1368.     CrossRef
• Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms
  Peter W. Szlosarek, Melissa M. Phillips, Iuliia Pavlyk, Jeremy Steele, Jonathan Shamash, James Spicer, Sanjeev Kumar, Simon Pacey, Xiaoxing Feng, Amanda Johnston, John Bomalaski, Graeme Moir, Kelvin Lau, Stephen Ellis, Michael Sheaff
  JTO Clinical and Research Reports.2020; 1(4): 100093.     CrossRef
• Selective extracellular arginine deprivation by a single injection of cellular non-uptake arginine deiminase nanocapsules for sustained tumor inhibition
  Hongzhao Qi, Yin Wang, Xubo Yuan, Peifeng Li, Lijun Yang
  Nanoscale.2020; 12(47): 24030.     CrossRef
• Role of amino acid metabolism in angiogenesis
  Roxana E. Oberkersch, Massimo M. Santoro
  Vascular Pharmacology.2019; 112: 17.     CrossRef
• Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
  Nishant Gandhi, Gokul Das
  Cells.2019; 8(2): 89.     CrossRef
• Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma
  Xuemei Tao, Qiaozhu Zuo, Haoyu Ruan, Hui Wang, Haojie Jin, Zhuoan Cheng, Yuanyuan Lv, Wenxin Qin, Cun Wang
  Acta Biochimica et Biophysica Sinica.2019; 51(3): 263.     CrossRef
• Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion
  Yin Cao, WenWen Ding, JingZi Zhang, Qi Gao, HaoXiang Yang, WangSen Cao, ZhongXia Wang, Lei Fang, RongHui Du
  Journal of Proteome Research.2019; 18(5): 2032.     CrossRef
• Isolation and screening of extracellular anticancer enzymes from halophilic and halotolerant bacteria from different saline environments in Iran
  Mahdis Zolfaghar, Mohammad Ali Amoozegar, Khosro Khajeh, Hamid Babavalian, Hamid Tebyanian
  Molecular Biology Reports.2019; 46(3): 3275.     CrossRef
• Arginine Deiminase: Current Understanding and Applications
  Mahboubeh Zarei, Mohammad Reza Rahbar, Mohammad Hossein Morowvat, Navid Nezafat, Manica Negahdaripour, Aydin Berenjian, Younes Ghasemi
  Recent Patents on Biotechnology.2019; 13(2): 124.     CrossRef
• The Diverse Functions of Non-Essential Amino Acids in Cancer
  Bo-Hyun Choi, Jonathan L. Coloff
  Cancers.2019; 11(5): 675.     CrossRef
• Amino Acid Degrading Enzymes and their Application in Cancer Therapy
  Vadim S. Pokrovsky, Olga E. Chepikova, Denis Zh. Davydov, Andrey A. Zamyatnin Jr, Alexander N. Lukashev, Elena V. Lukasheva
  Current Medicinal Chemistry.2019; 26(3): 446.     CrossRef
• Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer
  Lamia Mouhid, Marta Gómez de Cedrón, Elena García-Carrascosa, Guillermo Reglero, Tiziana Fornari, Ana Ramírez de Molina, Olga A. Sukocheva
  PLOS ONE.2019; 14(3): e0214294.     CrossRef
• Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity
  Ashraf S.A. El-Sayed, Ahmed A. Shindia, Azza A. Abou Zeid, Amany M. Yassin, Mahmoud Z. Sitohy, Basel Sitohy
  Enzyme and Microbial Technology.2019; 131: 109432.     CrossRef
• Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability
  Anke Werner, Daniel Pieh, Hakim Echchannaoui, Johanna Rupp, Krishnaraj Rajalingam, Matthias Theobald, Ellen I. Closs, Markus Munder
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors
  Bethany C. Prudner, Richa Rathore, Anthony M. Robinson, Abigail Godec, Samuel F. Chang, William G. Hawkins, Angela C. Hirbe, Brian A. Van Tine
  Clinical Cancer Research.2019; 25(16): 5122.     CrossRef
• Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM
  Lina Mörén, Richard Perryman, Tim Crook, Julia K. Langer, Kevin Oneill, Nelofer Syed, Henrik Antti
  BMC Cancer.2018;[Epub]     CrossRef
• Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20
  Sounak Gupta, Divya Sahu, John S. Bomalaski, Igor Frank, Stephen A. Boorjian, Prabin Thapa, John C. Cheville, Donna E. Hansel
  Endocrine Pathology.2018; 29(3): 236.     CrossRef
• Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy
  Mozhgan Jahani, Fatemeh Noroznezhad, Kamran Mansouri
  Biomedicine & Pharmacotherapy.2018; 102: 594.     CrossRef
• Identification of metabolites in plasma for predicting survival in glioblastoma
  Jie Shen, Renduo Song, Tiffany R. Hodges, Amy B. Heimberger, Hua Zhao
  Molecular Carcinogenesis.2018; 57(8): 1078.     CrossRef
• The Citrulline Recycling Pathway Sustains Cardiovascular Function in Arginine-Depleted Healthy Mice, but Cannot Sustain Nitric Oxide Production during Endotoxin Challenge
  Yang Yuan, Mahmoud A Mohammad, Ancizar Betancourt, Inka C Didelija, Chandrasekar Yallampalli, Juan C Marini
  The Journal of Nutrition.2018; 148(6): 844.     CrossRef
• Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes
  Constantinos Alexandrou, Saif Sattar Al-Aqbi, Jennifer A. Higgins, William Boyle, Ankur Karmokar, Catherine Andreadi, Jin-Li Luo, David A. Moore, Maria Viskaduraki, Matthew Blades, Graeme I. Murray, Lynne M. Howells, Anne Thomas, Karen Brown, Paul N. Chen
  Scientific Reports.2018;[Epub]     CrossRef
• Metal ions-induced stability and function of bimetallic human arginase-I, a therapeutically important enzyme
  Vineet Sadarangani, Safikur Rahman, Apurba Kumar Sau
  Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2018; 1866(11): 1153.     CrossRef
• Rewiring urea cycle metabolism in cancer to support anabolism
  Rom Keshet, Peter Szlosarek, Arkaitz Carracedo, Ayelet Erez
  Nature Reviews Cancer.2018; 18(10): 634.     CrossRef
• TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase
  Elena Brin, Katherine Wu, Eleanor Dagostino, Mario Meng-Chiang Kuo, Yudou He, Wei-Jong Shia, Li-Chang Chen, Mariusz Stempniak, Richard Hickey, Robert Almassy, Richard Showalter, James Thomson
  Oncotarget.2018; 9(97): 36914.     CrossRef
• Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell lines
  Somphon Roeksomtawin, Panida Navasumrit, Somchamai Waraprasit, Varabhorn Parnlob, Thaniya Sricharunrat, Vajarabhongsa Bhudhisawasdi, Niramol Savaraj, Mathuros Ruchirawat
  Oncology Letters.2018;[Epub]     CrossRef
• Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization
  C. Noreen Hinrichs, Mirjam Ingargiola, Theresa Käubler, Steffen Löck, Achim Temme, Alvaro Köhn-Luque, Andreas Deutsch, Olena Vovk, Oleh Stasyk, Leoni A. Kunz-Schughart
  Molecular Cancer Therapeutics.2018; 17(2): 393.     CrossRef
• Metabolic synthetic lethality in cancer therapy
  Vincent Zecchini, Christian Frezza
  Biochimica et Biophysica Acta (BBA) - Bioenergetics.2017; 1858(8): 723.     CrossRef
• Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase–Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase
  Divya Sahu, Sounak Gupta, Andrew M. Hau, Kazufumi Nakashima, Mariah Z. Leivo, Stephen C. Searles, Paul Elson, John S. Bomalaski, Darren E. Casteel, Gerry R. Boss, Donna E. Hansel
  The American Journal of Pathology.2017; 187(1): 200.     CrossRef
• Construction and in vitro evaluation of enzyme nanoreactors based on carboxymethyl chitosan for arginine deprivation in cancer therapy
  Tian Zeng, Yi Zhang, Qiongjiao Yan, Zhijun Huang, Ling Zhang, Xiaozhe Yi, Junrong Chen, Guanghua He, Yihua Yin
  Carbohydrate Polymers.2017; 162: 35.     CrossRef
• Drug target identification at the crossroad of neuronal apoptosis and survival
  Barbara Maino, Simona Paparone, Cinzia Severini, Maria Teresa Ciotti, Velia D’agata, Pietro Calissano, Sebastiano Cavallaro
  Expert Opinion on Drug Discovery.2017; 12(3): 249.     CrossRef
• Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
  Paulo C. Rodriguez, Augusto C. Ochoa, Amir A. Al-Khami
  Frontiers in Immunology.2017;[Epub]     CrossRef
• Understanding the Intersections between Metabolism and Cancer Biology
  Matthew G. Vander Heiden, Ralph J. DeBerardinis
  Cell.2017; 168(4): 657.     CrossRef
• Designing Smart Materials with Recombinant Proteins
  Sydney Hollingshead, Charng‐Yu Lin, Julie C. Liu
  Macromolecular Bioscience.2017;[Epub]     CrossRef
• Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
  Emma Beddowes, James Spicer, Pui Ying Chan, Ramsay Khadeir, Javier Garcia Corbacho, Dimitra Repana, Jeremy P. Steele, Peter Schmid, Teresa Szyszko, Gary Cook, Monica Diaz, Xiaoxing Feng, Amanda Johnston, Jim Thomson, Michael Sheaff, Bor-Wen Wu, John Bomal
  Journal of Clinical Oncology.2017; 35(16): 1778.     CrossRef
• Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
  Seema Gupta, Amrita Roy, Bilikere S. Dwarakanath
  Frontiers in Oncology.2017;[Epub]     CrossRef
• The interplay between metabolic remodeling and immune regulation in glioblastoma
  Pravin Kesarwani, Shiva Kant, Antony Prabhu, Prakash Chinnaiyan
  Neuro-Oncology.2017; 19(10): 1308.     CrossRef
• PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction
  Mamta Verma, Ramya Chandar M. Charles, Baskar Chakrapani, Mohane Selvaraj Coumar, Gayathri Govindaraju, Arumugam Rajavelu, Sreenivas Chavali, Arunkumar Dhayalan
  Journal of Molecular Biology.2017; 429(15): 2278.     CrossRef
• Technetium-99m complexes ofl-arginine derivatives for targeting amino acid transporters
  Maurício Morais, Vera F. C. Ferreira, Flávio Figueira, Filipa Mendes, Paula Raposinho, Isabel Santos, Bruno L. Oliveira, João D. G. Correia
  Dalton Transactions.2017; 46(42): 14537.     CrossRef
• Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
  Gabriela Andrejeva, Jeffrey C. Rathmell
  Cell Metabolism.2017; 26(1): 49.     CrossRef
• Proteomic and Metabolomic Characterization of a Mammalian Cellular Transition from Quiescence to Proliferation
  Ho-Joon Lee, Mark P. Jedrychowski, Arunachalam Vinayagam, Ning Wu, Ng Shyh-Chang, Yanhui Hu, Chua Min-Wen, Jodene K. Moore, John M. Asara, Costas A. Lyssiotis, Norbert Perrimon, Steven P. Gygi, Lewis C. Cantley, Marc W. Kirschner
  Cell Reports.2017; 20(3): 721.     CrossRef
• A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
  Maeve A. Lowery, Kenneth H. Yu, David Paul Kelsen, James J. Harding, John S. Bomalaski, Danielle C. Glassman, Christina M. Covington, Robin Brenner, Ellen Hollywood, Adalberto Barba, Amanda Johnston, Kay Chia‐Wei Liu, Xiaoxing Feng, Marinela Capanu, Ghass
  Cancer.2017; 123(23): 4556.     CrossRef
• A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
  Hui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, Gautam Borthakur, Sheng-Fung Lin, Naveen Pemmaraju, Elias Jabbour, John S. Bomalaski, Ya-Ping Chen, Hui-Hua Hsiao, Ming-Chung Wang, Ching-Yuan Kuo, Hung Chang, Su-Peng Yeh, Jorge Cortes, Li-Tzong Chen, Tsai-Y
  Scientific Reports.2017;[Epub]     CrossRef
• Targeting Metabolism for Cancer Therapy
  Alba Luengo, Dan Y. Gui, Matthew G. Vander Heiden
  Cell Chemical Biology.2017; 24(9): 1161.     CrossRef
• Proliferation of sphere-forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine
  Minoru Tomizawa, Fuminobu Shinozaki, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige
  Oncology Letters.2017; 13(3): 1264.     CrossRef
• PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration
  Elena Brin, Katherine Wu, Hsin-Tze Lu, Yudou He, Zhaoming Dai, Wei He
  Oncotarget.2017; 8(35): 58948.     CrossRef
• Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents
  W-B Tsai, Y Long, J-R Park, J T Chang, H Liu, J Rodriguez-Canales, N Savaraj, L G Feun, M A Davies, I I Wistuba, M T Kuo
  Oncogene.2016; 35(13): 1632.     CrossRef
• Comparative proteome analysis across non-small cell lung cancer cell lines
  Kathrin Grundner-Culemann, J. Nikolaj Dybowski, Martin Klammer, Andreas Tebbe, Christoph Schaab, Henrik Daub
  Journal of Proteomics.2016; 130: 1.     CrossRef
• Arginine deprivation induces endoplasmic reticulum stress in human solid cancer cells
  Yaroslav Bobak, Yuliya Kurlishchuk, Bozhena Vynnytska-Myronovska, Olesia Grydzuk, Galyna Shuvayeva, Maria J. Redowicz, Leoni A. Kunz-Schughart, Oleh Stasyk
  The International Journal of Biochemistry & Cell Biology.2016; 70: 29.     CrossRef
• Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells
  Tzyy-Harn Yeh, Yun-Ru Chen, Szu-Ying Chen, Wei-Chiang Shen, David K. Ann, Jennica L. Zaro, Li-Jiuan Shen
  Molecular Pharmaceutics.2016; 13(1): 262.     CrossRef
• Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy
  Lifeng Xiong, Jade Teng, Michael Botelho, Regina Lo, Susanna Lau, Patrick Woo
  International Journal of Molecular Sciences.2016; 17(3): 363.     CrossRef
• Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug
  Rui-Zhi Han, Guo-Chao Xu, Jin-Jun Dong, Ye Ni
  Applied Microbiology and Biotechnology.2016; 100(11): 4747.     CrossRef
• Arginine dependence of tumor cells: targeting a chink in cancer’s armor
  M D Patil, J Bhaumik, S Babykutty, U C Banerjee, D Fukumura
  Oncogene.2016; 35(38): 4957.     CrossRef
• The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?
  Giuseppe Bronte, Lorena Incorvaia, Sergio Rizzo, Francesco Passiglia, Antonio Galvano, Fabio Rizzo, Christian Rolfo, Daniele Fanale, Angela Listì, Clara Natoli, Viviana Bazan, Antonio Russo
  Critical Reviews in Oncology/Hematology.2016; 107: 20.     CrossRef
• Serine and one-carbon metabolism in cancer
  Ming Yang, Karen H. Vousden
  Nature Reviews Cancer.2016; 16(10): 650.     CrossRef
• Argininosuccinate Synthetase 1 (ASS1) Is a Common Metabolic Marker of Chemosensitivity for Targeted Arginine- and Glutamine-Starvation Therapy
  Yan Long, Wen-Bin Tsai, Dajuan Wang, David H. Hawke, Niramol Savaraj, Lynn G. Feun, Mien-Chie Hung, Helen H.W. Chen, Macus Tien Kuo
  Cancer Letters.2016;[Epub]     CrossRef
• Tissue metabolic profiling of lymph node metastasis of colorectal cancer assessed by 1H NMR
  Hailong Zhang, Liang Qiao, Xiaopeng Li, Yang Wan, Li Yang, Huijuan Wang
  Oncology Reports.2016; 36(6): 3436.     CrossRef
• Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes
  Hua Zhao, Amy B. Heimberger, Zhimin Lu, Xifeng Wu, Tiffany R. Hodges, Renduo Song, Jie Shen
  Oncotarget.2016; 7(15): 20486.     CrossRef
• c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma
  Yari Ciribilli, Prashant Singh, Alberto Inga, Jürgen Borlak
  Oncotarget.2016; 7(40): 65514.     CrossRef
• Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation
  Yan Long, Wen-Bin Tsai, Jeffrey T. Chang, Marcos Estecio, Medhi Wangpaichitr, Naramol Savaraj, Lynn G. Feun, Helen H.W. Chen, Macus Tien Kuo
  Oncotarget.2016; 7(50): 82658.     CrossRef
• Co-application of canavanine and irradiation uncouples anticancer potential of arginine deprivation from citrulline availability
  Yuliya Kurlishchuk, Bozhena Vynnytska-Myronovska, Philipp Grosse-Gehling, Yaroslav Bobak, Friederike Manig, Oleg Chen, Sebastian R. Merker, Thomas Henle, Steffen Löck, Daniel E. Stange, Oleh Stasyk, Leoni A. Kunz-Schughart
  Oncotarget.2016; 7(45): 73292.     CrossRef
• Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond
  Elitsa A Ananieva, Jonathan D Powell, Susan M Hutson
  Advances in Nutrition.2016; 7(4): 798S.     CrossRef
• Arginine deprivation in cancer therapy
  Lynn G. Feun, Macus Tien Kuo, Niramol Savaraj
  Current Opinion in Clinical Nutrition and Metabolic Care.2015; 18(1): 78.     CrossRef
• Recombinant arginine‐degrading enzymes in metabolic anticancer therapy and bioanalytics
  Oleh V. Stasyk, Yuriy R. Boretsky, Mykhailo V. Gonchar, Andriy A. Sibirny
  Cell Biology International.2015; 39(3): 246.     CrossRef
• Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy
  Ann E. Walts, John S. Bomalaski, Delma Ines, Sandra Orsulic
  Journal of Cancer Research and Clinical Oncology.2015; 141(8): 1363.     CrossRef
• Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model
  Shih-Chang Shiue, Miao-Zeng Huang, Ting-Fen Tsai, Alice Chien Chang, Kong Bung Choo, Chiu-Jung Huang, Tsung-Sheng Su
  Journal of Biomedical Science.2015;[Epub]     CrossRef
• Perioperative dynamics and significance of amino acid profiles in patients with cancer
  Yu Gu, Tianxiang Chen, Suzhen Fu, Xin Sun, Lingyan Wang, Jian Wang, Yingfeng Lu, Songming Ding, Guodong Ruan, Lisong Teng, Min Wang
  Journal of Translational Medicine.2015;[Epub]     CrossRef
• Nitric oxide synthase in innate and adaptive immunity: an update
  Christian Bogdan
  Trends in Immunology.2015; 36(3): 161.     CrossRef
• Searching for targets for the systemic therapy of mesothelioma
  R.A. Stahel, W. Weder, E. Felley-Bosco, U. Petrausch, A. Curioni-Fontecedro, I. Schmitt-Opitz, S. Peters
  Annals of Oncology.2015; 26(8): 1649.     CrossRef
• Targeting arginine metabolism pathway to treat arginine-dependent cancers
  Fuming Qiu, Jian Huang, Meihua Sui
  Cancer Letters.2015; 364(1): 1.     CrossRef
• Arginine deprivation by arginine deiminase ofStreptococcus pyogenescontrols primary glioblastoma growthin vitroandin vivo
  Tomas Fiedler, Madlen Strauss, Silvio Hering, Ulrike Redanz, Doreen William, Yvonne Rosche, Carl Friedrich Classen, Bernd Kreikemeyer, Michael Linnebacher, Claudia Maletzki
  Cancer Biology & Therapy.2015; 16(7): 1047.     CrossRef
• Arginine addiction in AML
  William Plunkett
  Blood.2015; 125(26): 3971.     CrossRef
• Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo
  Farideh Miraki-Moud, Essam Ghazaly, Linda Ariza-McNaughton, Katharine A. Hodby, Andrew Clear, Fernando Anjos-Afonso, Konstantinos Liapis, Marianne Grantham, Fareeda Sohrabi, Jamie Cavenagh, John S. Bomalaski, John G. Gribben, Peter W. Szlosarek, Dominique
  Blood.2015; 125(26): 4060.     CrossRef
• Therapeutic interventions to disrupt the protein synthetic machinery in melanoma
  Gregory R. Kardos, Gavin P. Robertson
  Pigment Cell & Melanoma Research.2015; 28(5): 501.     CrossRef
• Research into cancer metabolomics: Towards a clinical metamorphosis
  Orianne Olivares, J. Henry M. Däbritz, Ayala King, Eyal Gottlieb, Christina Halsey
  Seminars in Cell & Developmental Biology.2015; 43: 52.     CrossRef
• Argininosuccinate lyase is a potential therapeutic target in breast cancer
  HAU-LUN HUANG, WEI-CHING CHEN, HUI-PING HSU, CHIEN-YU CHO, YU-HSUAN HUNG, CHIH-YANG WANG, MING-DERG LAI
  Oncology Reports.2015; 34(6): 3131.     CrossRef
• Arginine Depletion by Arginine Deiminase Does Not Affect Whole Protein Metabolism or Muscle Fractional Protein Synthesis Rate in Mice
  Juan C. Marini, Inka Cajo Didelija, Zane Andrews
  PLOS ONE.2015; 10(3): e0119801.     CrossRef
• Targeting amino acid metabolism in cancer growth and anti-tumor immune response
  Elitsa Ananieva
  World Journal of Biological Chemistry.2015; 6(4): 281.     CrossRef
• Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14
  Alison N. McCracken, Aimee L. Edinger
  Biochemical Journal.2015; 470(3): e17.     CrossRef
• l-Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells
  Matthew Fletcher, Maria E. Ramirez, Rosa A. Sierra, Patrick Raber, Paul Thevenot, Amir A. Al-Khami, Dulfary Sanchez-Pino, Claudia Hernandez, Dorota D. Wyczechowska, Augusto C. Ochoa, Paulo C. Rodriguez
  Cancer Research.2015; 75(2): 275.     CrossRef
• A transgenic approach to study argininosuccinate synthetase gene expression
  Shih-Chang Shiue, Miao-Zeng Huang, Tsung-Sheng Su
  Journal of Biomedical Science.2014;[Epub]     CrossRef
• The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials
  Anna Synakiewicz, Teresa Stachowicz-Stencel, Elzbieta Adamkiewicz-Drozynska
  Expert Opinion on Investigational Drugs.2014; 23(11): 1517.     CrossRef
• Arginine deprivation and autophagic cell death in cancer
  Peter Wojciech Szlosarek
  Proceedings of the National Academy of Sciences.2014; 111(39): 14015.     CrossRef
• Cellular Serpents and Dreaming Spires: New Frontiers in Arginine and Pyrimidine Biology
  Gabriel N. Aughey, Ömür Y. Tastan, Ji-Long Liu
  Journal of Genetics and Genomics.2014; 41(10): 561.     CrossRef
• Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer
  Rouzbeh Daylami, Diego J Muilenburg, Subbulakshmi Virudachalam, Richard J Bold
  Journal of Experimental & Clinical Cancer Research.2014;[Epub]     CrossRef
• Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
  Jennifer A McAlpine, Hsin-Tze Lu, Katherine C Wu, Susan K Knowles, James A Thomson
  BMC Cancer.2014;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: a nationwide study from 2012 to 2018
  Sara Kwon, Kyuwoong Kim, Bohyun Park, So-Jung Park, Hyun Jung Jho, Jin Young Choi
  BMC Palliative Care.2024;[Epub]     CrossRef
• Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer
  Gopika SenthilKumar, Sharadhi Madhusudhana, Madelyn Flitcroft, Salma Sheriff, Samih Thalji, Jennifer Merrill, Callisia N. Clarke, Ugwuji N. Maduekwe, Susan Tsai, Kathleen K. Christians, T. Clark Gamblin, Anai N. Kothari
  Scientific Reports.2023;[Epub]     CrossRef
• A prospective cohort study assessing aggressive interventions at the end-of-life among patients with solid metastatic cancer
  Chetna Malhotra, Filipinas Bundoc, Isha Chaudhry, Irene Teo, Semra Ozdemir, Eric Finkelstein, Rebecca A. Dent, Nesaretnam Barr Kumarakulasinghe, Yin Bun Cheung, Rahul Malhotra, Ravindran Kanesvaran, Alethea Chung Pheng Yee, Noreen Chan, Huei Yaw Wu, Soh M
  BMC Palliative Care.2022;[Epub]     CrossRef
• Quality of End-of-Life Care in Gastrointestinal Cancers: A 13-Year Population-Based Retrospective Analysis in Ontario, Canada
  Caitlin SR Lees, Hsien Seow, Kelvin KW Chan, Anastasia Gayowsky, Aynharan Sinnarajah
  Current Oncology.2022; 29(12): 9163.     CrossRef
• Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study
  Joost Besseling, Jan Reitsma, Judith A. Van Erkelens, Maike H. J. Schepens, Michiel P. C. Siroen, Cathelijne M. P. Ziedses des Plantes, Mark I. van Berge Henegouwen, Laurens V. Beerepoot, Theo Van Voorthuizen, Lia Van Zuylen, Rob H. A. Verhoeven, Hanneke
  Cancers.2021; 13(1): 145.     CrossRef
• Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews
  M. Santero, J. Pérez-Bracchiglione, R. Acosta-Dighero, A. G. Meade, A. Antequera, A. Auladell-Rispau, M. J. Quintana, C. Requeijo, G. Rodríguez-Grijalva, K. Salas-Gama, R. Dorantes-Romandia, J. Salazar, I. Solà, G. Urrútia, X. Bonfill Cosp
  BMC Cancer.2021;[Epub]     CrossRef
• Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts
  Helena Ullgren, Per Fransson, Anna Olofsson, Ralf Segersvärd, Lena Sharp, Amir Radfar
  PLOS ONE.2021; 16(7): e0254673.     CrossRef
• Health care utilization among patients with oesophageal and gastric cancer: the impact of initial treatment strategy and assignment of a contact nurse
  Karin Dalhammar, Marlene Malmström, Magnus Sandberg, Dan Falkenback, Jimmie Kristensson
  BMC Health Services Research.2021;[Epub]     CrossRef
• Conceptualizing and Counting Discretionary Utilization in the Final 100 Days of Life: A Scoping Review
  Paul R. Duberstein, Michael Chen, Michael Hoerger, Ronald M. Epstein, Laura M. Perry, Sule Yilmaz, Fahad Saeed, Supriya G. Mohile, Sally A. Norton
  Journal of Pain and Symptom Management.2020; 59(4): 894.     CrossRef
• The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study
  Karin Dalhammar, Marlene Malmström, Maria Schelin, Dan Falkenback, Jimmie Kristensson, Jason Chia-Hsun Hsieh
  PLOS ONE.2020; 15(6): e0235045.     CrossRef
• Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer
  Si Won Lee, Hyun Jung Jho, Ji Yeon Baek, Eun Kyung Shim, Hyun Mi Kim, Ji Yeon Ku, Eun Jung Nam, Yoon-Jung Chang, Hye Jin Choi, Sun Young Kim
  American Journal of Hospice and Palliative Medicine®.2018; 35(1): 166.     CrossRef
• Patterns and Yearly Time Trends in the Use of Radiation Therapy During the Last 30 Days of Life Among Patients With Metastatic Rectal Cancer in the United States From 2004 to 2012
  Adan Z. Becerra, Christian P. Probst, Fergal J. Fleming, Zhaomin Xu, Christopher T. Aquina, Carla F. Justiniano, Courtney I. Boodry, Alex A. Swanger, Katia Noyes, Alan W. Katz, John R. Monson, Todd A. Jusko
  American Journal of Hospice and Palliative Medicine®.2018; 35(2): 336.     CrossRef
• Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective
  Delong Liu, Dhruv Mehta, Supreet Kaur, Arun Kumar, Kaushal Parikh, Lavneet Chawla, Shanti Patel, Amirta Devi, Aparna Saha
  Journal of Hematology & Oncology.2018;[Epub]     CrossRef
• Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma
  Eli L. Diamond, Katherine S. Panageas, Alexis Dallara, Ariel Pollock, Allison J. Applebaum, Alan C. Carver, Elena Pentsova, Lisa M. DeAngelis, Holly G. Prigerson
  Journal of Pain and Symptom Management.2017; 53(2): 257.     CrossRef
• The effects of hospice-shared care for gastric cancer patients
  Kun-Siang Huang, Shih-Ho Wang, Seng-Kee Chuah, Kun-Ming Rau, Yu-Hung Lin, Meng-Che Hsieh, Li-Hsueh Shih, Yen-Hao Chen, Ramon Andrade de Mello
  PLOS ONE.2017; 12(2): e0171365.     CrossRef
• Clinical significance and predicting indicators of post‐cancer‐treatment survival in terminally ill patients with ovarian cancer
  Fumi Utsumi, Hiroaki Kajiyama, Kaoru Niimi, Ryuichiro Sekiya, Jun Sakata, Shiro Suzuki, Kiyosumi Shibata, Mika Mizuno, Fumitaka Kikkawa
  Journal of Obstetrics and Gynaecology Research.2017; 43(2): 365.     CrossRef
• Adopting Advance Directives Reinforces Patient Participation in End-of-Life Care Discussion
  Ji Hyung Hong, Jung Hye Kwon, Il Kyu Kim, Jin Hee Ko, Yi-Jin Kang, Hoon-Kyo Kim
  Cancer Research and Treatment.2016; 48(2): 753.     CrossRef
• Cases and Literature Review of Timing for Withdrawal of Palliative Chemotherapy
  Yun Jin Jeong, Do Yeun Kim
  The Korean Journal of Hospice and Palliative Care.2016; 19(1): 70.     CrossRef
• End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study
  I. Gallais Sérézal, Y. Beaussant, P. Rochigneux, C. Tournigand, R. Aubry, B. Lindelöf, L. Morin
  British Journal of Dermatology.2016; 175(3): 583.     CrossRef
• Trends in the Aggressiveness of End-of-Life Cancer Care in the State of Qatar
  Azza A. Hassan, Hassan Mohsen, Ayman A. Allam, Pascale Haddad
  Journal of Global Oncology.2016; 2(2): 68.     CrossRef
• Investigational tests and treatments performed in terminal stage cancer patients in two weeks before death: Turkish oncology group (TOG) study
  İbrahim Türker, Şeref Kömürcü, Ali Arıcan, Hatice Doruk, Özgür Özyılkan, Hasan Şenol Coşkun, Dilşen Çolak, Emel Üçgül Çavuşoğlu, Alper Ata, Ahmet Sezer, Havva Yeşil Çınkır, Filiz Çay Şenler, Fikret Arpacı
  Medical Oncology.2014;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Maintenance chemotherapy for esophageal squamous cell carcinoma after standard concurrent chemoradiotherapy: a national propensity score matching cohort study
  Szu-Wen Tseng
  American Journal of Cancer Research.2024; 14(5): 2300.     CrossRef
• Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT
  Geng Xiang, Chunsheng Xu, Guangjin Chai, Bo Lyu, Zhaohui Li, Bin Wang, Mei Shi, Lina Zhao
  Radiation Oncology.2023;[Epub]     CrossRef
• Prognostic factors for 495 nonoperative esophageal squamous cancer patients receiving IMRT plus chemotherapy: A retrospective analysis
  Q. Gao, Z.-Y. Liu, Y. Cheng, X.-K. Di, Y.-M. Zhang, X.-C. Sun, X.-J. Xia, X.-L. Ge
  Cancer/Radiothérapie.2022; 26(8): 1002.     CrossRef
• Irradiation-induced exosomal HMGB1 to confer radioresistance via the PI3K/AKT/FOXO3A signaling pathway in ESCC
  Xingyu Du, Xueyuan Zhang, Jing Dong, Naiyi Zou, Dong Guo, Weinan Yao, Xiaobin Wang, Shuguang Li, Chunyang Song, Ke Yan, Wenbin Shen, Shuchai Zhu
  Journal of Translational Medicine.2022;[Epub]     CrossRef
• A comparison between raltitrexed plus cisplatin and docetaxel plus cisplatin in concurrent chemoradiation for non-surgical esophageal squamous cell carcinoma
  X. Xia, Z. Liu, B. Cai, X. Di, X. Sun, X. Ge
  Cancer/Radiothérapie.2021; 25(1): 39.     CrossRef
• Long-Term Survival in Nonsurgical Esophageal Cancer Patients Who Received Consolidation Chemotherapy Compared With Patients Who Received Concurrent Chemoradiotherapy Alone: A Systematic Review and Meta-Analysis
  Xiaojie Xia, Zeyuan Liu, Qin Qin, Xiaoke Di, Zhaoyue Zhang, Xinchen Sun, Xiaolin Ge
  Frontiers in Oncology.2021;[Epub]     CrossRef
• High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis
  Baoqing Chen, Meiling Deng, Chen Yang, Mihnea P. Dragomir, Lei Zhao, Kunhao Bai, Mian Xi, Yonghong Hu, Yujia Zhu, Qiaoqiao Li
  Radiotherapy and Oncology.2021; 158: 191.     CrossRef
• Prognostic Significance of Interim Response Evaluation during Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
  Jun Gi Yeom, Jie-Hyun Kim, Jun Won Kim, Yeona Cho, Ik Jae Lee, Chang Geol Lee, Jaeyoung Chun, Young Hoon Youn, Hyojin Park
  Cancers.2021; 13(6): 1255.     CrossRef
• Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
  Xi-Lei Zhou, Chang-Hua Yu, Wan-Wei Wang, Fu-Zhi Ji, Yao-Zu Xiong, Wei-Guo Zhu, Yu-Suo Tong
  Radiation Oncology.2021;[Epub]     CrossRef
• Clinical Outcomes and Prognostic Factors of Salvage Treatment for Local Lymph Node Recurrence After Radical Resection of Oesophageal Carcinoma
  Liang Gu, Yangchen Liu, Hongxue Ye, Fei Gao, Xiaoxiang Yin, Ying Zhao, Ye Tian
  Cancer Management and Research.2021; Volume 13: 5845.     CrossRef
• Chemoradiotherapy Is Superior to Radiotherapy Alone in Esophageal Cancer Patients Older Than 65 Years: A Propensity Score-Matched Analysis of the SEER Database
  Xiaojie Xia, Qing Gao, Xiaolin Ge, Zeyuan Liu, Xiaoke Di, Xinchen Sun, Yan Yang
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis
  Jianing Wang, Linlin Xiao, Shuai Wang, Qingsong Pang, Jun Wang
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients
  Ao Liu, Yalin Wang, Xin Wang, Liqiong Zhu, Yu Nie, Minghuan Li
  Radiation Oncology.2021;[Epub]     CrossRef
• Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
  An-Du Zhang, Xiao-Hua Su, Gao-Feng Shi, Chun Han, Lan Wang, Hui Liu, Jun Zhang, Ruo-Hui Zhang
  Archives of Medical Research.2020; 51(5): 419.     CrossRef
• Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
  Xiujuan Xu, Zhongming Wang, Shunian Jiang, Yuping Shang, Yan Wu
  Radiation Oncology.2019;[Epub]     CrossRef
• Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma
  Ying Yang, Jun Jia, Zhiwei Sun, Feng Du, Jing Yu, Chuanling Liu, Yanjie Xiao, Xiaodong Zhang, Qingyi Wei
  PLOS ONE.2017; 12(8): e0182660.     CrossRef
• The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
  Hyun-Jeong Shim, Min-Ho Shin, Hee-Nam Kim, Jo-Heon Kim, Jun-Eul Hwang, Woo-Kyun Bae, Ik-Joo Chung, Sang-Hee Cho
  Cancer Research and Treatment.2016; 48(1): 71.     CrossRef
• Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
  Yong-Hyub Kim, Sang-Yun Song, Hyun-Jeong Shim, Woong-Ki Chung, Sung-Ja Ahn, Mee Sun Yoon, Jae-Uk Jeong, Ju-Young Song, Taek-Keun Nam
  Radiation Oncology Journal.2015; 33(1): 12.     CrossRef
• Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer
  Eun Jin Yoo, Jun Chul Park, Eun Hye Kim, Chan Hyuk Park, Choong Nam Shim, Hyun Jik Lee, Hyun Soo Chung, Hyuk Lee, Sung Kwan Shin, Sang Kil Lee, Chang Geol Lee, Yong Chan Lee
  Digestive and Liver Disease.2014; 46(9): 846.     CrossRef

Citations

Citations to this article as recorded by  

• A population-based investigation: How to identify high-risk T1-2N0 esophageal cancer patients?
  Peng Luo, Jie Wu, Xiankai Chen, Yafan Yang, Ruixiang Zhang, Xiuzhu Qi, Yin Li
  Frontiers in Surgery.2023;[Epub]     CrossRef
• Low-Dose Versus High-Dose Radiation Therapy for the Palliation of Dysphagia From Esophageal Cancer: A Multicenter Retrospective Cohort Study
  Bram D. Vermeulen, Paul M. Jeene, Jasmijn Sijben, Robin Krol, Heidi Rütten, Johannes A. Bogers, Pètra M. Braam, Peter D. Siersema
  Practical Radiation Oncology.2020; 10(4): e255.     CrossRef
• Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles
  Qingxia Fu, Jiancheng Wang, Hong Liu
  Drug Delivery.2020; 27(1): 1535.     CrossRef
• A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study
  Xin Tang, Xiaojuan Zhou, Yanying Li, Xue Tian, Yongsheng Wang, Meijuan Huang, Li Ren, Lin Zhou, Zhenyu Ding, Jiang Zhu, Yong Xu, Feng Peng, Jin Wang, You Lu, Youling Gong
  Annals of Surgical Oncology.2019; 26(2): 321.     CrossRef
• SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer
  Héctor van den Boorn, Ameen Abu-Hanna, Emil ter Veer, Jessy van Kleef, Florian Lordick, Michael Stahl, Jaffer Ajani, Rosine Guimbaud, Se Park, Susan Dutton, Yung-Jue Bang, Narikazu Boku, Nadia Mohammad, Mirjam Sprangers, Rob Verhoeven, Aeilko Zwinderman,
  Cancers.2019; 11(2): 187.     CrossRef
• Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
  Yoichi Hamai, Jun Hihara, Manabu Emi, Takaoki Furukawa, Yuji Murakami, Ikuno Nishibuchi, Yuta Ibuki, Ichiko Yamakita, Tomoaki Kurokawa, Yasushi Nagata, Morihito Okada
  World Journal of Surgery.2018; 42(5): 1496.     CrossRef
• Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis
  H. G. van den Boorn, E. G. Engelhardt, J. van Kleef, M. A. G. Sprangers, M. G. H. van Oijen, A. Abu-Hanna, A. H. Zwinderman, V. M. H. Coupé, H. W. M. van Laarhoven, Masaru Katoh
  PLOS ONE.2018; 13(2): e0192310.     CrossRef
• Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review
  Vaibhav Gupta, Natalie Coburn, Biniam Kidane, Kenneth R. Hess, Carolyn Compton, Jolie Ringash, Gail Darling, Alyson L. Mahar
  The Journal of Thoracic and Cardiovascular Surgery.2018; 156(2): 847.     CrossRef
• First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control
  Nuria Kotecki, Sandrine Hiret, Pierre-Luc Etienne, Nicolas Penel, Emmanuelle Tresch, Eric François, Marie Pierre Galais, Meher Ben Abdelghani, Pierre Michel, Laetitia Dahan, François Ghiringelli, Laurent Bedenne, Emmanuelle Samalin, Guillaume Piessen, Jaf
  Oncology.2016; 90(2): 88.     CrossRef
• Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with Pazopanib
  Michael W. Kattan, Cora N. Sternberg, Faisal Mehmud, Kamal Bhatt, Lauren McCann, Robert J. Motzer
  Oncology.2015; 89(4): 235.     CrossRef
• Nomogram to Predict Treatment Outcome of Fluoropyrimidine/Platinum-Based Chemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
  Hyun Ae Jung, Antoine Adenis, Jeeyun Lee, Se Hoon Park, Chi Hoon Maeng, Silvia Park, Hee Kyung Ahn, Young Mog Shim, Nicolas Penel, Young-Hyuck Im
  Cancer Research and Treatment.2013; 45(4): 285.     CrossRef

Citations

Citations to this article as recorded by  

• Predictive factors for severe radiation-induced lung injury in patients with lung cancer and coexisting interstitial lung disease
  Shin-Hyung Park, Jae-Kwang Lim, Min Kyu Kang, Jongmoo Park, Chae Moon Hong, Chang Ho Kim, Seung Ick Cha, Jaehee Lee, Seoung-Jun Lee, Jae-Chul Kim
  Radiotherapy and Oncology.2024; 192: 110053.     CrossRef
• Deep-Learning Model Prediction of Radiation Pneumonitis Using Pretreatment Chest Computed Tomography and Clinical Factors
  Jang Hyung Lee, Min Kyu Kang, Jongmoo Park, Seoung-Jun Lee, Jae-Chul Kim, Shin-Hyung Park
  Technology in Cancer Research & Treatment.2024;[Epub]     CrossRef
• Pulmonary toxicity of craniospinal irradiation using helical tomotherapy
  Joongyo Lee, Euidam Kim, Nalee Kim, Chang-Ok Suh, Yoonsun Chung, Hong In Yoon
  Scientific Reports.2022;[Epub]     CrossRef
• Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors
  Xin Zhang, Dingyi Yang, Yong Jiang, Luo Huang, Can Wang, Dan Tao, Xianfeng Liu, Yongyang Lei, Yongzhong Wu, Wei Zhou
  Journal of Inflammation Research.2021; Volume 14: 4205.     CrossRef
• The Efficacy and Safety of Acupuncture for Preventing Radiation Pneumonitis in Patients With Lung Cancer: A Prospective, Single-Blinded, Randomized Pilot Proof-of-Principle Study
  Moonkyoo Kong, Seung Hyeun Lee, Jaehyo Kim, Beom-Joon Lee, Kwan-Il Kim
  Integrative Cancer Therapies.2020;[Epub]     CrossRef
• Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non–small-cell lung cancer
  Tomohiro Itonaga, Ryuji Mikami, Hidetsugu Nakayama, Tatsuhiko Saito, Sachika Shiraishi, Mitsuru Okubo, Shinji Sugahara, Norihiko Ikeda, Koichi Tokuuye
  Journal of Radiation Research.2019; 60(3): 387.     CrossRef
• Dosimetric Comparison Between Jaw Tracking and No Jaw Tracking in Intensity-Modulated Radiation Therapy
  Shengyu Yao, Yin Zhang, Tingfeng Chen, Guoqi Zhao, Zhekai Hu, Xiaokai Lu, Yong Liu
  Technology in Cancer Research & Treatment.2019;[Epub]     CrossRef
• A new Monte Carlo model of a Cyberknife® system for the precise determination of out-of-field doses
  J Colnot, V Barraux, C Loiseau, P Berejny, A Batalla, R Gschwind, C Huet
  Physics in Medicine & Biology.2019; 64(19): 195008.     CrossRef
• Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours
  Stefano Arcangeli, Lorenzo Falcinelli, Stefano Bracci, Alessandro Greco, Alessia Monaco, Jessica Dognini, Cinzia Chiostrini, Rita Bellavita, Cynthia Aristei, Vittorio Donato
  The British Journal of Radiology.2017;[Epub]     CrossRef
• Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC
  S Arcangeli, L Agolli, L Portalone, M R Migliorino, M G Lopergolo, A Monaco, J Dognini, M C Pressello, S Bracci, V Donato
  The British Journal of Radiology.2015; 88(1048): 20140728.     CrossRef
• Early Toxicity in Patients Treated With Postoperative Proton Therapy for Locally Advanced Breast Cancer
  John J. Cuaron, Brian Chon, Henry Tsai, Anuj Goenka, David DeBlois, Alice Ho, Simon Powell, Eugen Hug, Oren Cahlon
  International Journal of Radiation Oncology*Biology*Physics.2015; 92(2): 284.     CrossRef
• Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental rats
  Xianglan Zhang, You Keun Shin, Zhenlong Zheng, Lianhua Zhu, Ik Jae Lee
  Radiation Oncology.2015;[Epub]     CrossRef
• Dosimetric Comparisons of Lung SBRT with Multiple Metastases by Two Advanced Planning Systems
  Ye Zhang, Yie Chen, Jie Qiu, Jack Yang
  International Journal of Medical Physics, Clinical Engineering and Radiation Oncology.2014; 03(04): 252.     CrossRef
• Frameless stereotactic body radiation therapy for multiple lung metastases
  Qilin Li, Jinming Mu, Wendong Gu, Yuan Chen, Zhonghua Ning, Jianxue Jin, Honglei Pei
  Journal of Applied Clinical Medical Physics.2014; 15(4): 105.     CrossRef

Citations

Citations to this article as recorded by  

• Therapeutic vaccines for colorectal cancer: The progress and future prospect
  Mina Shahnazari, Pouria Samadi, Mona Pourjafar, Akram Jalali
  International Immunopharmacology.2020; 88: 106944.     CrossRef
• Vaccines for colorectal cancer: an update
  Mostafa Sarvizadeh, Faezeh Ghasemi, Fatemeh Tavakoli, Sara Sadat Khatami, Ebrahim Razi, Hossein Sharifi, Nousin Moussavi Biouki, Mohsen Taghizadeh
  Journal of Cellular Biochemistry.2019; 120(6): 8815.     CrossRef
• Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season
  Maria Ganczak, Paulina Dubiel, Marzena Drozd-Dąbrowska, Ewelina Hallmann-Szelińska, Karol Szymański, Lidia B. Brydak
  International Journal of Environmental Research and Public Health.2019; 16(22): 4489.     CrossRef
• Immunogenicity of Influenza Vaccination in Patients With Cancer
  Saiama N. Waqar, Leigh Boehmer, Daniel Morgensztern, Andrea Wang-Gillam, Steven Sorscher, Steven Lawrence, Feng Gao, Kalin Guebert, Kristina Williams, Ramaswamy Govindan
  American Journal of Clinical Oncology.2018; 41(3): 248.     CrossRef
• Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy
  Kei Nakashima, Masahiro Aoshima, Satoko Ohfuji, Kanzo Suzuki, Masahiro Katsurada, Naoko Katsurada, Masafumi Misawa, Yoshihito Otsuka, Kyoko Kondo, Yoshio Hirota
  Human Vaccines & Immunotherapeutics.2017; 13(3): 543.     CrossRef
• Influenza vaccination in adult patients with solid tumours treated with chemotherapy
  Albert Vollaard, Imke Schreuder, Lizzy Slok-Raijmakers, Wim Opstelten, Guus Rimmelzwaan, Hans Gelderblom
  European Journal of Cancer.2017; 76: 134.     CrossRef
• Vaccination in Patients with Primary Immune Deficiency, Secondary Immune Deficiency and Autoimmunity with Immune Regulatory Abnormalities
  Martha M Eibl, Hermann M Wolf
  Immunotherapy.2015; 7(12): 1273.     CrossRef

Citations

Citations to this article as recorded by  

• Association between Toll-like receptor 2 rs4696483 and rs1898830 polymorphisms and the risk of triple-negative breast cancer
  Rabeb M. Ghali, Sonia Zaied, Amira Daldoul, Perizat Kanabekova, Wassim Y. Almawi
  Gene.2024; 928: 148773.     CrossRef
• Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene
  Eglė Žilienė, Arturas Inčiūra, Rasa Ugenskienė, Elona Juozaitytė
  Diagnostics.2023; 13(12): 1999.     CrossRef
• Ranking and Prioritizing Risk Factors for Gastric Cancer
  Ali Reza Yusefi, Shima Bordbar, Gholamhossein Mehralian, Kamran Bagheri Lankarani, Mohammad Khammarnia, Zahra Kavosi, Peivand Bastani
  The Open Public Health Journal.2023;[Epub]     CrossRef
• Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis
  Ayoub Al Othaim, Sulieman Ibraheem Shelash Al-Hawary, Hashem O. Alsaab, Sami G. Almalki, Mazin A. A. Najm, Ahmed Hjazi, Ali Alsalamy, Abbas Firras Almulla, Hamzeh Alizadeh
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Association between EPHA5 methylation status in peripheral blood leukocytes and the risk and prognosis of gastric cancer
  Xu Han, Tianyu Liu, Jiabao Zhai, Chang Liu, Wanyu Wang, Chuang Nie, Qi Wang, Xiaojie Zhu, Haibo Zhou, Wenjing Tian
  PeerJ.2022; 10: e13774.     CrossRef
• Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate
  Debashis Dutta, Moumita Majumder, Ramesh Kumar Paidi, Kalipada Pahan
  Neurobiology of Disease.2021; 153: 105318.     CrossRef
• Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice
  Donghui Cao, Zhifang Jia, Yanhua Wu, Tongrong Su, Dan Zhao, Menghui Wu, Tetsuya Tsukamoto, Masanobu Oshima, Jing Jiang, Xueyuan Cao
  Life Sciences.2020; 263: 118580.     CrossRef
• Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract
  Evagelia Spanou, Polyxeni Kalisperati, Ioannis S. Pateras, Alexandros Papalampros, Alexandra Barbouti, Athanasios G. Tzioufas, Athanassios Kotsinas, Stavros Sougioultzis
  Frontiers in Genetics.2017;[Epub]     CrossRef
• Increased deaths from gastric cancer in communities living close to waste landfills
  Agostino Di Ciaula
  International Journal of Environmental Health Research.2016; 26(3): 281.     CrossRef
• Correlation of Serum Levels of Endostatin with Tumor Stage in Gastric Cancer: A Systematic Review and Meta-Analysis
  Zheng-Hua Wang, Zhi-Tu Zhu, Xu-Yang Xiao, Jin Sun
  BioMed Research International.2015; 2015: 1.     CrossRef
• Pattern-Recognition Receptors and Gastric Cancer
  Natalia Castaño-Rodríguez, Nadeem O. Kaakoush, Hazel M. Mitchell
  Frontiers in Immunology.2014;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
  Daniel S.W. Tan, Enriqueta Felip, Gilberto de Castro, Benjamin J. Solomon, Alastair Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis Paz-Ares, Jaafar Bennouna, Marina Chiara Garassino, Michael Schenker, Sang-We K
  Journal of Clinical Oncology.2024; 42(2): 192.     CrossRef
• Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 t
  Luis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, Balazs Halmos, Byoung Chul Cho, Manuel Cobo, José Luis González Larriba, Caicun Zhou, Ingel Demedts, Akin Atmaca, Sofia Baka, Bijoyesh Mookerjee, Socorro Portella, Zewen Zhu, Jincheng Wu, David Demanse, Bh
  Lung Cancer.2024; 189: 107451.     CrossRef
• Targeting Notch-Driven Cytokine Secretion: Novel Therapies for Triple Negative Breast Cancer
  Wanda Marini, Brooke E. Wilson, Michael Reedijk
  DNA and Cell Biology.2023; 42(2): 73.     CrossRef
• IL-1β is involved in docetaxel chemoresistance by regulating the formation of polyploid giant cancer cells in non-small cell lung cancer
  Song Zhao, Sining Xing, Lili Wang, Mingyue Ouyang, Shuo Liu, Lingyan Sun, Huiying Yu
  Scientific Reports.2023;[Epub]     CrossRef
• Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma
  Tingting Li, Huanqing Liu, Chunsheng Dong, Jun Lyu
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
  Mélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, Caroline Truntzer, Elise Ballot, Romain Boidot, Cindy Racoeur, Emilie Barsac, Fanny Chalmin, Christophe Hibos, Thomas Baranek, Christophe Paget, Bernhard Ryffel, Cédric Rébé, Catherine Paul, Frédérique
  Nature Immunology.2022; 23(2): 262.     CrossRef
• Targeting interleukin-1β and inflammation in lung cancer
  Jun Zhang, Nirmal Veeramachaneni
  Biomarker Research.2022;[Epub]     CrossRef
• Immunohistochemical Detection of Pro-Inflammatory and Anti-Inflammatory Interleukins in the Lungs of Sheep with Jaagsiekte
  Emin KARAKURT, Enver BEYTUT, Serpil DAĞ, Hilmi NUHOĞLU, Ayfer YILDIZ, Emre KURTBAŞ
  Turkish Journal of Veterinary Research.2022; 6(1): 9.     CrossRef
• Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System
  Ana Belén Herrera-Campos, Esteban Zamudio-Martinez, Daniel Delgado-Bellido, Mónica Fernández-Cortés, Luis M. Montuenga, F. Javier Oliver, Angel Garcia-Diaz
  Cancers.2022; 14(11): 2740.     CrossRef
• Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
  Mark P. Lythgoe, Vinay Prasad
  British Journal of Cancer.2022; 127(5): 785.     CrossRef
• Promotion of angiogenesis in vitro by Astragalus polysaccharide via activation of TLR4 signaling pathway
  Huiqing Qiu, Liyan Zhang, Xinqi He, Yusen Wei, Miaoran Wang, Bin Ma, Dailun Hu, Zhongli Shi
  Journal of Food Biochemistry.2022;[Epub]     CrossRef
• B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
  Anqi Lin, Jianbo Fang, Quan Cheng, Zaoqu Liu, Peng Luo, Jian Zhang
  Journal of Inflammation Research.2022; Volume 15: 5541.     CrossRef
• Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer
  Giuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, Veronica Mollica, Alessio Cortellini, Sara Elena Rebuzzi, Arsela Prelaj, Abdul Rafeh Naqash, Edouard Auclin, Lucia Garetto, Laura Mezquita, Alfredo Addeo
  Current Oncology Reports.2022; 24(12): 1851.     CrossRef
• IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients
  Marzia Spagnardi, Jenny Paredes, Jovanny Zabaleta, Jone Garai, Tiana Reyes, Laura A. Martello, Jennie L. Williams
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Immune Resistance in Lung Adenocarcinoma
  Magda Spella, Georgios T. Stathopoulos
  Cancers.2021; 13(3): 384.     CrossRef
• The Role of Tumor Inflammatory Microenvironment in Lung Cancer
  Zhaofeng Tan, Haibin Xue, Yuli Sun, Chuanlong Zhang, Yonglei Song, Yuanfu Qi
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Interleukin-1β and Cancer
  Cédric Rébé, François Ghiringhelli
  Cancers.2020; 12(7): 1791.     CrossRef
• Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
  Hailiang Liu, Yong Xu, Kai Liang, Rong Liu
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
  Michela Terlizzi, Chiara Colarusso, Ilaria De Rosa, Pasquale Somma, Carlo Curcio, Rita P. Aquino, Luigi Panico, Rosario Salvi, Federica Zito Marino, Gerardo Botti, Aldo Pinto, Rosalinda Sorrentino
  Journal of Experimental & Clinical Cancer Research.2020;[Epub]     CrossRef
• A review of canakinumab and its therapeutic potential for non-small cell lung cancer
  Kara M. Schenk, Joshua E. Reuss, Karin Choquette, Alexander I. Spira
  Anti-Cancer Drugs.2019; 30(9): 879.     CrossRef
• Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity
  Zachary T. Morrow, Zachary M. Powers, John-Demian Sauer
  Current Clinical Microbiology Reports.2019; 6(4): 213.     CrossRef
• Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging
  Ahmed Salem, Hitesh Mistry, Alison Backen, Clare Hodgson, Pek Koh, Emma Dean, Lynsey Priest, Kate Haslett, Ioannis Trigonis, Alan Jackson, Marie-Claude Asselin, Caroline Dive, Andrew Renehan, Corinne Faivre-Finn, Fiona Blackhall
  Clinical Lung Cancer.2018; 19(3): 239.     CrossRef
• Elucidating the Role of CD84 and AHR in Modulation of LPS-Induced Cytokines Production by Cruciferous Vegetable-Derived Compounds Indole-3-Carbinol and 3,3′-Diindolylmethane
  Thomas Wang, Quynhchi Pham, Young Kim
  International Journal of Molecular Sciences.2018; 19(2): 339.     CrossRef
• IL‐1β promotes the nuclear translocaiton of S100A4 protein in gastric cancer cells MGC803 and the cell's stem‐like properties through PI3K pathway
  Aiwen Yu, Yu Wang, Yue Bian, Lisha Chen, Junfu Guo, Wei Shen, Danqi Chen, Shanshan Liu, Xiuju Sun
  Journal of Cellular Biochemistry.2018; 119(10): 8163.     CrossRef
• SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients
  Camille Emprou, Pauline Le Van Quyen, Jérémie Jégu, Nathalie Prim, Noëlle Weingertner, Eric Guérin, Erwan Pencreach, Michèle Legrain, Anne‐Claire Voegeli, Charlotte Leduc, Bertrand Mennecier, Pierre‐Emmanuel Falcoz, Anne Olland, Nicolas Santelmo, Elisabet
  Cancer Medicine.2018; 7(7): 3278.     CrossRef
• RNA-Sequencing data supports the existence of novel VEGFA splicing events but not of VEGFAxxxb isoforms
  Stephen Bridgett, Margaret Dellett, David A. Simpson
  Scientific Reports.2017;[Epub]     CrossRef
• Cordycepin inhibits LPS-induced inflammatory responses by modulating NOD-Like Receptor Protein 3 inflammasome activation
  Jing Yang, Yun-zhou Li, Phillip B. Hylemon, Lu-yong Zhang, Hui-ping Zhou
  Biomedicine & Pharmacotherapy.2017; 95: 1777.     CrossRef
• Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Poor Prognosis in Small-cell Lung Cancer
  Xu Wang, Min Liu, Lei Zhang, Kewei Ma
  Archives of Medical Research.2016; 47(1): 19.     CrossRef
• Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms
  Alexander Kaltenborn, Svenja Matzke, Moritz Kleine, Till Krech, Wolf Ramackers, Florian W. R. Vondran, Jürgen Klempnauer, Hüseyin Bektas, Harald Schrem
  Journal of Surgical Oncology.2016; 113(2): 194.     CrossRef
• Association of CT perfusion imaging with plasma levels of TGF-β1 and VEGF in patients with NSCLC
  Da-Wei Li, Bao-Zhong Wu, Yu-Sen Shi, Zhi-Qun Li, Xu-Dong Liu, Xiao-Hua Li
  Asian Pacific Journal of Tropical Medicine.2016; 9(2): 177.     CrossRef
• Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model
  Anne-Marie Baird, Steven G. Gray, Derek J. Richard, Kenneth J. O’Byrne
  Scientific Reports.2016;[Epub]     CrossRef
• Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity
  Kristian Hargadon
  Journal of Clinical Medicine.2016; 5(9): 76.     CrossRef
• Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis
  Bryant R. England, Jeremy Sokolove, William H. Robinson, Geoffrey M. Thiele, Apar K. Ganti, Harlan Sayles, Kaleb Michaud, Liron Caplan, Lisa A. Davis, Grant W. Cannon, Brian Sauer, Namrata Singh, E. Blair Solow, Andreas M. Reimold, Gail S. Kerr, Pascale S
  Arthritis & Rheumatology.2016; 68(10): 2394.     CrossRef
• The inflammasome: an emerging therapeutic oncotarget for cancer prevention
  Wang Zhiyu, Neng Wang, Qi Wang, Cheng Peng, Jin Zhang, Pengxi Liu, Aihua Ou, Shaowen Zhong, Mario D. Cordero, Yi Lin
  Oncotarget.2016; 7(31): 50766.     CrossRef
• Elevated chronic inflammatory factors and myeloid‐derived suppressor cells indicate poor prognosis in advanced melanoma patients
  Huanhuan Jiang, Christoffer Gebhardt, Ludmila Umansky, Philipp Beckhove, Torsten J. Schulze, Jochen Utikal, Viktor Umansky
  International Journal of Cancer.2015; 136(10): 2352.     CrossRef
• The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer
  Shu-Guang Liu, Shuang-Hu Yuan, Hui-Yong Wu, Jie Liu, Cheng-Suo Huang
  Cell Biochemistry and Biophysics.2015; 72(1): 165.     CrossRef
• Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients
  Bao-Hong Fu, Zhan-Zhao Fu, Wei Meng, Tao Gu, Xiao-Dong Sun, Zhi Zhang
  Tumor Biology.2015; 36(8): 6477.     CrossRef
• Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy
  Morena Fasano, Carminia Maria Della Corte, Federica Papaccio, Fortunato Ciardiello, Floriana Morgillo
  Journal of Thoracic Oncology.2015; 10(8): 1133.     CrossRef
• The angiogenic responses induced by release of angiogenic proteins from tumor cell‐activated platelets are regulated by distinct molecular pathways
  Hongyan Wu, Fangtian Fan, Zhaoguo Liu, Feng Zhang, Yuping Liu, Zhonghong Wei, Cunsi Shen, Yuzhu Cao, Aiyun Wang, Yin Lu
  IUBMB Life.2015; 67(8): 626.     CrossRef
• Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
  Sonia Blanco-Prieto, Lorena Vázquez-Iglesias, Mar Rodríguez-Girondo, Leticia Barcia-Castro, Alberto Fernández-Villar, María Isabel Botana-Rial, Francisco Javier Rodríguez-Berrocal, María Páez de la Cadena, Rossella Rota
  PLOS ONE.2015; 10(5): e0127318.     CrossRef

Citations

Citations to this article as recorded by  

• Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An Overview
  Elsie Neo Seane, Shankari Nair, Charlot Vandevoorde, Anna Joubert
  Pharmaceuticals.2024; 17(5): 602.     CrossRef
• Investigation of geroprotective and radioprotective effects of berberine and trichostatin A on the model of Drosophila melanogaster
  N. Ulyasheva, E. Proshkina, M. Shaposhnikov, A. Moskalev
  Proceedings of the Komi Science Centre of the Ural Division of the Russian Academy of Sciences.2023; 0(6): 93.     CrossRef
• Low Dose of Trichostatin A Improves Radiation Resistance by Activating Akt/Nrf2-Dependent Antioxidation Pathway in Cancer Cells
  Fengqiu Zhang, Changsheng Shao, Zhu Chen, Yalin Li, Xumiao Jing, Qing Huang
  Radiation Research.2021;[Epub]     CrossRef
• Time-sequential change in immune-related gene expression after irradiation in glioblastoma: next-generation sequencing analysis
  Yi-Jun Kim, Kwangsoo Kim, Soo Yeon Seo, Juyeon Yu, Il Han Kim, Hak Jae Kim, Chul-Kee Park, Kye Hwa Lee, Junjeong Choi, Myung Seon Song, Jin Ho Kim
  Animal Cells and Systems.2021; 25(4): 245.     CrossRef
• Is level of acetylation directly correlated to radiation sensitivity of cancer cell?
  Fengqiu Zhang, Zhu Chen, Changsheng Shao, Qing Huang
  Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.2019; 813: 13.     CrossRef
• Disulfiram, a Re-positioned Aldehyde Dehydrogenase Inhibitor, Enhances Radiosensitivity of Human Glioblastoma Cells In Vitro
  Hyeon Kang Koh, Soo Yeon Seo, Jin Ho Kim, Hak Jae Kim, Eui Kyu Chie, Seung-Ki Kim, Il Han Kim
  Cancer Research and Treatment.2019; 51(2): 696.     CrossRef
• Psammaplin A-Modified Novel Radiosensitizers for Human Lung Cancer and Glioblastoma Cells
  Chan Woo Wee, Jin Ho Kim, Hak Jae Kim, Hyun-Cheol Kang, Soo Youn Suh, Beom Soo Shin, Eunsook Ma, Il Han Kim
  Journal of Radiation Protection and Research.2019; 44(1): 15.     CrossRef
• Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization
  Jin Ho Kim, Sung Ho Moon, Mina No, Jae Jin Kim, Eun Jung Choi, Bong Jun Cho, Jae Sung Kim, Il Han Kim, In Ah Kim
  Cancer Research and Treatment.2016; 48(3): 1130.     CrossRef

Citations

Citations to this article as recorded by  

• Spontaneous tumour lysis syndrome as a rare presentation of thymoma with peripheral blood lymphocytosis
  Larry E Nyanti, Andy Sing Ong Tang, Adam Malik b Ismail, Lee Ping Chew, Tze Shin Leong
  Proceedings of Singapore Healthcare.2022;[Epub]     CrossRef
• Tumor Lysis Syndrome in Patients With Solid Tumors: A Systematic Review of Reported Cases
  Riyadh M Alqurashi , Husam H Tamim, Ziyad D Alsubhi, Alyazid A Alzahrani, Emad Tashkandi
  Cureus.2022;[Epub]     CrossRef
• Spontaneous tumour lysis syndrome in cervical cancer
  Yu Kyung Kim, Ji Yeon Ham, Won-Kil Lee, Kyung Eun Song
  Journal of Obstetrics and Gynaecology.2017; 37(5): 679.     CrossRef
• Ifosfamide/mesna/paclitaxel
  
  Reactions Weekly.2015; 1547(1): 151.     CrossRef
• Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature
  Aibek E. Mirrakhimov, Alaa M. Ali, Maliha Khan, Aram Barbaryan
  Rare Tumors.2014; 6(2): 68.     CrossRef

Citations

Citations to this article as recorded by  

• The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
  Alessandra Cinque, Roberto Minnei, Matteo Floris, Francesco Trevisani
  Cancers.2022; 14(21): 5352.     CrossRef
• Hereditary renal cell tumors: Clinicopathologic importance
  Harmanjot Singh, Mukul K. Divatia, Donghwa Baek, Jae Y. Ro
  annals of urologic oncology.2021;[Epub]     CrossRef

• Von Hippel-Lindau Disease: Current Challenges and Future Prospects

  
  Sven Gläsker, Evelynn Vergauwen, Christian A Koch, Alexander Kutikov, Alexander O Vortmeyer
  OncoTargets and Therapy.2020; Volume 13: 5669.     CrossRef
• The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
  Song Peng, Jun Zhang, Xintao Tan, Yiqiang Huang, Jing Xu, Natalie Silk, Dianzheng Zhang, Qiuli Liu, Jun Jiang
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights
  Maria I. Carlo, A. Ari Hakimi, Grant D. Stewart, Gennady Bratslavsky, James Brugarolas, Ying-Bei Chen, W. Marston Linehan, Eamonn R. Maher, Maria J. Merino, Kenneth Offit, Victor E. Reuter, Brian Shuch, Jonathan A. Coleman
  European Urology.2019; 76(6): 754.     CrossRef
• The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients
  Kaifang Ma, Baoan Hong, Jingcheng Zhou, Yanqing Gong, Jiangyi Wang, Shengjie Liu, Xiang Peng, Bowen Zhou, Jiufeng Zhang, Haibiao Xie, Kenan Zhang, Lei Li, Desheng Cai, Zixin Wang, Lin Cai, Kan Gong
  Frontiers in Oncology.2019;[Epub]     CrossRef
• A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease
  Gang Yuan, Qiuli Liu, Dali Tong, Gaolei Liu, Yuting Yi, Jun Zhang, Yao Zhang, Lin-ang Wang, Luofu Wang, Rongrong Chen, Yanfang Guan, Xin Yi, Weihua Lan, Jun Jiang
  Cancer Biology & Therapy.2018; 19(9): 766.     CrossRef
• Genetic Predisposition to Renal Cell Carcinoma: Implications for Counseling, Testing, Screening, and Management
  Brian Shuch, Jin Zhang
  Journal of Clinical Oncology.2018; 36(36): 3560.     CrossRef
• A Case of von Hippel–Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
  Su Jin Heo, Choong-kun Lee, Kyu Yeon Hahn, Gyuri Kim, Hyuk Hur, Sung Hoon Choi, Kyung Seok Han, Arthur Cho, Minkyu Jung
  Cancer Research and Treatment.2016; 48(1): 409.     CrossRef
• Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease
  Akihiro Kobayashi, Masanobu Takahashi, Hiroo Imai, Shoko Akiyama, Shunsuke Sugiyama, Keigo Komine, Ken Saijo, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Naomi Sato, Fumiyoshi Fujishima, Taro Shuin, Hideki Shimodaira, Chikashi Ishioka
  Internal Medicine.2016; 55(6): 629.     CrossRef
• Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group
  Stéphane Oudard, Reza Elaidi, Mara Brizard, Céline Le Rest, Valérie Caillet, Sophie Deveaux, Gérard Benoit, Jean-Michel Corréas, Farida Benoudiba, Philippe David, Alain Gaudric, Pascal Hammel, Dominique Joly, Marc Olivier Timsit, Arnaud Méjean, Stéphane R
  Oncotarget.2016; 7(51): 85306.     CrossRef
• Pharmacogenomic biomarkers for personalized cancer treatment
  C. Rodríguez‐Antona, M. Taron
  Journal of Internal Medicine.2015; 277(2): 201.     CrossRef
• Pharmacological HIF2α inhibition improves VHL disease–associated phenotypes in zebrafish model
  Ana Martins Metelo, Haley R. Noonan, Xiang Li, Youngnam Jin, Rania Baker, Lee Kamentsky, Yiyun Zhang, Ellen van Rooijen, Jordan Shin, Anne E. Carpenter, Jing-Ruey Yeh, Randall T. Peterson, Othon Iliopoulos
  Journal of Clinical Investigation.2015; 125(5): 1987.     CrossRef
• Molecular and immunologic markers of kidney cancer—potential applications in predictive, preventive and personalized medicine
  Amanda Mickley, Olga Kovaleva, Julia Kzhyshkowska, Alexei Gratchev
  EPMA Journal.2015;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Sarcoidosis-Like Reaction After Chemotherapy Mimicking Metastasis in a Patient With Two Synchronous Tumors: A Case Report
  Sandra Silva, João Fernandes, Sérgio Campainha, Agostinho Sanches, Cristiana Marques
  Cureus.2024;[Epub]     CrossRef
• A case of endobronchial metastasis of colon cancer mimics sarcoidosis, and a review of related literature
  Hui Lv, Yi Shao, Qiu-Song Chen, Wen-Jing Song, Li-Na Peng, Dian-Sheng Zhong
  Journal of Cancer Research and Clinical Oncology.2023; 149(16): 15287.     CrossRef
• Subcutaneous sarcoidosis (Darier–Roussy sarcoidosis) with extensive disease on positron emission tomography: A case report and review of the literature
  Paul Youn, Roslyn J. Francis, Henry Preston, Fiona Lake
  Respirology Case Reports.2022;[Epub]     CrossRef
• De Novo Presentation of Sarcoidosis on Restaging FDG PET/CT in Rectal Carcinoma With Self-resolution
  Sampath Santhosh, Godwin Jeeva, Raja Thirumalairaj
  Clinical Nuclear Medicine.2021; 46(1): e40.     CrossRef
• Sarcoid-Like Reaction after Complete Remission of Malignancy: CT and 18F-FDG PET/CT Features for the Differential Diagnosis from Lymph Node Metastasis
  Hyun Ji Kang, Yookyung Kim, June Young Bae, Jung Hyun Chang, Soo-Hyun Lee
  Journal of the Korean Society of Radiology.2021; 82(4): 903.     CrossRef
• Subcutaneous sarcoidosis of the upper and lower extremities: A case report and review of the literature
  Raman Mehrzad, Julia Festa, Reena Bhatt
  World Journal of Clinical Cases.2019; 7(17): 2505.     CrossRef
• Endometriosis resembling endometrial cancer in a postmenopausal patient
  B. Suchońska, M. Gajewska, A. Zyguła, M. Wielgoś
  Climacteric.2018; 21(1): 88.     CrossRef
• Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT
  Prateek Sanan, Yang Lu
  Clinical Nuclear Medicine.2017; 42(9): 702.     CrossRef
• Coexistence of sarcoidosis and metastatic lesions: A diagnostic and therapeutic dilemma (Review)
  Christoph Spiekermann, Meike Kuhlencord, Sebastian Huss, Claudia Rudack, Daniel Wei�
  Oncology Letters.2017;[Epub]     CrossRef
• Granulomatosis after autologous stem cell transplantation in nonHodgkin lymphoma – experience of single institution and a review of literature
  Lucka Boltezar, Ivana Zagar, Barbara Jezersek Novakovic
  Radiology and Oncology.2016; 50(4): 355.     CrossRef
• Discovery of Splenic Sarcoidosis Concurrent with the Diagnosis of Ovarian Cancer: A Case Report
  Eun-Heui Kim, Seung-Geun Lee, Ki-Hyung Kim, Young-Mi Seol, Eun-Kyoung Park, Dong-Wan Koo, Na-Kyoung Hwang, In-Sub Han, Moon-Won Lee, Sung-Yong Han, Geun-Tae Kim, Hee-Sang Tag
  Journal of Rheumatic Diseases.2016; 23(2): 130.     CrossRef
• Sarcoidosis in gastric cancer at the time of diagnosis: A case report
  YANG JIAO, JIE NING, WEN-DI ZHAO, YAN-LI LI, HONG-YANG WU, KANG-SHENG GU
  Oncology Letters.2015; 9(3): 1159.     CrossRef
• Sarcoidosis of female reproductive organs in a postmenopausal woman
  Monika Zurkova, Marie Turkova, Tomas Tichy, Radovan Pilka, Vitezslav Kolek, Eva Kriegova
  Menopause.2015; 22(5): 549.     CrossRef
• Sarcoidosis Occurring After Solid Cancer
  Aurélie Grados, Mikael Ebbo, Emmanuelle Bernit, Véronique Veit, Karin Mazodier, Rodolphe Jean, Diane Coso, Thérèse Aurran-Schleinitz, Florence Broussais, Reda Bouabdallah, Gwenaelle Gravis, Anthony Goncalves, Marc Giovaninni, Pascal Sève, Bruno Chetaille,
  Medicine.2015; 94(28): e928.     CrossRef
• Sarcoid‐like reaction mimicking vaginal cancer recurrence
  Michinori Mayama, Masato Yoshihara, Mayu Ukai, Shinya Kondo, Yasuyuki Kishigami, Hidenori Oguchi
  Journal of Obstetrics and Gynaecology Research.2015; 41(11): 1855.     CrossRef
• Carboplatin/paclitaxel
  
  Reactions Weekly.2014; 1497(1): 14.     CrossRef